These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pravastatin prevents arrhythmias induced by coronary artery ischemia/reperfusion in anesthetized normocholesterolemic rats. Chen J; Nagasawa Y; Zhu BM; Ohmori M; Harada K; Fujimura A; Hashimoto K J Pharmacol Sci; 2003 Sep; 93(1):87-94. PubMed ID: 14501157 [TBL] [Abstract][Full Text] [Related]
3. Pravastatin Decreases Infarct Size Induced by Coronary Artery Ischemia/Reperfusion with Elevated eNOS Expression in Rats. Li H; Wang C; Sun J; Liu C; Li N; Chen J Int Heart J; 2018; 59(1):154-160. PubMed ID: 29375110 [TBL] [Abstract][Full Text] [Related]
4. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group. Jacotot B; Benghozi R; Pfister P; Holmes D Am J Cardiol; 1995 Jul; 76(2):54A-56A. PubMed ID: 7604799 [TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of pravastatin against lethal ventricular arrhythmias induced by reperfusion in the rat heart. Thuc LC; Teshima Y; Takahashi N; Nishio S; Fukui A; Kume O; Ezaki K; Miyazaki H; Yufu K; Hara M; Nakagawa M; Saikawa T Circ J; 2011; 75(7):1601-8. PubMed ID: 21613743 [TBL] [Abstract][Full Text] [Related]
6. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia. Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798 [TBL] [Abstract][Full Text] [Related]
7. Fluvastatin versus pravastatin. Chilton R Am J Cardiol; 1996 Jul; 78(1):127. PubMed ID: 8712106 [No Abstract] [Full Text] [Related]
8. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. Eichstädt HW; Eskötter H; Hoffman I; Amthauer HW; Weidinger G Am J Cardiol; 1995 Jul; 76(2):122A-125A. PubMed ID: 7604786 [TBL] [Abstract][Full Text] [Related]
9. Fluvastatin in combination with rad significantly reduces graft vascular disease in rat cardiac allografts. Gregory CR; Katznelson S; Griffey SM; Kyles AE; Berryman ER Transplantation; 2001 Sep; 72(6):989-93. PubMed ID: 11579289 [TBL] [Abstract][Full Text] [Related]
10. Reduction of myocardial infarct size by fluvastatin. Tiefenbacher CP; Kapitza J; Dietz V; Lee CH; Niroomand F Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H59-64. PubMed ID: 12623790 [TBL] [Abstract][Full Text] [Related]
11. Effects of statins on circulating oxidized low-density lipoprotein in patients with hypercholesterolemia. Inami S; Okamatsu K; Takano M; Takagi G; Sakai S; Sano J; Mizuno K Jpn Heart J; 2004 Nov; 45(6):969-75. PubMed ID: 15655272 [TBL] [Abstract][Full Text] [Related]
12. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects. Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of fluvastatin at doses insufficient to lower serum lipids on the catheter-induced thickening of intima in rabbit femoral artery. Bandoh T; Mitani H; Niihashi M; Kusumi Y; Ishikawa J; Kimura M; Totsuka T; Sakurai I; Hayashi S Eur J Pharmacol; 1996 Nov; 315(1):37-42. PubMed ID: 8960862 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia. Leitersdorf E; Muratti EN; Eliav O; Peters TK Am J Cardiol; 1995 Jul; 76(2):84A-88A. PubMed ID: 7604807 [TBL] [Abstract][Full Text] [Related]
15. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group. Bard JM; Ose L; Hagen E; Duriez P; Pfister P; Fruchart JC; Dallongeville J Am J Cardiol; 1995 Jul; 76(2):65A-70A. PubMed ID: 7604802 [TBL] [Abstract][Full Text] [Related]
16. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits. Mendoza S; Gamez R; Mas R; Goicochea E Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189 [TBL] [Abstract][Full Text] [Related]
17. Effects of fluvastatin on human biliary lipids. Tazuma S; Ohya T; Mizuno T; Takizawa I; Kunita T; Takata K; Hayashi K; Hino F; Tokumo H; Watanabe T Am J Cardiol; 1995 Jul; 76(2):110A-113A. PubMed ID: 7604783 [TBL] [Abstract][Full Text] [Related]
18. Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal. Pedersen TR; Tobert JA Drug Saf; 1996 Jan; 14(1):11-24. PubMed ID: 8713485 [TBL] [Abstract][Full Text] [Related]
19. Open-label study to assess the efficacy, safety, and tolerability of fluvastatin versus bezafibrate for hypercholesterolemia. Fanghänel G; Espinosa J; Olivares D; Sánchez L; Morales M; Martínez L; Macías G; Valdés E; Hernández G Am J Cardiol; 1995 Jul; 76(2):57A-61A. PubMed ID: 7604800 [TBL] [Abstract][Full Text] [Related]
20. Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine. Holdaas H; Hartmann A; Stenstrøm J; Dahl KJ; Borge M; Pfister P Am J Cardiol; 1995 Jul; 76(2):102A-106A. PubMed ID: 7604781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]